Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed By Donor Stem Cell Transplantation and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
This study is ongoing, but not recruiting participants.
Study NCT00008177
Information provided by Fred Hutchinson Cancer Research Center
First Received on January 6, 2001.
Last Updated on March 11, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
